Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small cell lung cancer: Results of a phase 1/2 trial: Comment

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)2-4
Number of pages3
JournalInternational Journal of Radiation Oncology Biology Physics
Volume87
Issue number1
DOIs
StatePublished - Sep 1 2013

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this